Also, we demonstrated that abnormal SPP was significantly associated with cutaneous and renal manifestations at PAD evaluation and had the predictive potential for progression to ESKD during follow-up in patients with AAV. This evidence concerns the gene HM13 and anti-neutrophil cytoplasmic antibody-associated vasculitis.